For example, the PD-L1 expression was found to be a good prognosis factor in NSCLC, colorectal cancer, and thymic carcinoma [27–29], but a poor prognosis factor in lung squamous cell carcinoma, renal cell carcinoma, and gastric carcinoma [30–32]. This evidence concerns the gene CD274 and renal cell carcinoma.